'This drug saved my life;' cystic fibrosis patient accuses drug company, Canada of stalling on approval

CTV News

17 November 2019 - A West Island woman living with cystic fibrosis says the prohibitive price of a drug is costing Canadian lives.

Chelsea Gagnon said she believes the drug Symdeko, which stabilizes patients’ lung degeneration by fixing protein deficiencies, saved her life.

“I’m certain that if I had not started this medication I would have deteriorated so much that I would have needed a double lung transplant or I would be dead,” she said.

Read CTV News article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , Market access , Canada